Home HOME Neoplasma 2022 Neoplasma Vol.69, No.2, p.484–490, 2022

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.69, No.2, p.484–490, 2022

Title: Clinicopathological characteristics and prognosis of breast cancer patients with lung cancer: A study based on 19,807 breast cancer patients
Author: Jin-Zhao Liu, Wei-Fang Zhang, Xiao-Fei Ren, Geng Zhang, Chao Yang, Shuo Zhang, Xiang-Mei Zhang, Yun-Jiang Liu

Abstract:

This study was conducted to investigate the clinicopathological characteristics and prognosis of breast cancer and lung cancer (BC-LC) and provide a theoretical basis for the diagnosis and treatment of BC-LC in clinical work. A retrospective study was conducted on breast cancer (BC) patients in our center from September 2009 to November 2020. The patients were divided into the BC-LC group and the control group. The control group was matched with both, the age at diagnosis and the time of surgery (± 1 year).

The clinicopathological factors, overall survival (OS), and hazard ratios (HRs) were evaluated by SPSS. A total of 19,807 BC patients were identified, among whom 124 (0.6%) had lung cancer (LC). Larger BC tumor was the only independent risk factor (OR = 2.454, p < 0.001) for development of LC in BC patients. We found inferior survival in patients with synchronous versus metachronous BC-LC (p = 0.008). We also identified combined with hypertension (HR = 3.917, p = 0.003) was an independent prognostic factor for inferior OS. Therefore, BC patients with larger tumors need close follow-up. Effective prevention and active treatment of hypertension can improve the OS of BC-LC patients.



Keywords: breast cancer; lung cancer; second primary malignancy; clinicopathological characteristics; prognosis
Published online: 10-Mar-2022
Year: 2022, Volume: 69, Issue: 2 Page From: 484, Page To: 490
doi:10.4149/neo_2022_210821N1197
Price: 14.70 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.